Sodium Salt of Acifluorfen; Pesticide Tolerances, 48383-48388 [2023-15900]
Download as PDF
48383
Federal Register / Vol. 88, No. 143 / Thursday, July 27, 2023 / Rules and Regulations
commercial operations or programs and
policies.’’
The WVDEP did not evaluate
environmental justice considerations as
part of its SIP submittal; the CAA and
applicable implementing regulations
neither prohibit nor require such an
evaluation. EPA did not perform an EJ
analysis and did not consider EJ in this
action. Consideration of EJ is not
required as part of this action, and there
is no information in the record
inconsistent with the stated goal of E.O.
12898 of achieving environmental
justice for people of color, low-income
populations, and Indigenous peoples.
B. Submission to Congress and the
Comptroller General
The Congressional Review Act, 5
U.S.C. 801 et seq., as added by the Small
Business Regulatory Enforcement
Fairness Act of 1996, generally provides
that before a rule may take effect, the
agency promulgating the rule must
submit a rule report, which includes a
copy of the rule, to each House of the
Congress and to the Comptroller General
of the United States. EPA will submit a
report containing this action and other
required information to the U.S. Senate,
the U.S. House of Representatives, and
the Comptroller General of the United
States prior to publication of the rule in
the Federal Register. A major rule
cannot take effect until 60 days after it
is published in the Federal Register.
This action is not a ‘‘major rule’’ as
defined by 5 U.S.C. 804(2).
C. Petitions for Judicial Review
Under section 307(b)(1) of the CAA,
petitions for judicial review of this
action must be filed in the United States
Court of Appeals for the appropriate
circuit by September 25, 2023. Filing a
petition for reconsideration by the
Administrator of this final rule does not
affect the finality of this action for the
purposes of judicial review nor does it
extend the time within which a petition
for judicial review may be filed, and
shall not postpone the effectiveness of
such rule or action. This action,
approving the West Virginia SIP
revision updating its incorporation by
reference of EPA’s NAAQS and
associated ambient air monitoring
reference methods and equivalent
methods, may not be challenged later in
proceedings to enforce its requirements.
(See section 307(b)(2).)
List of Subjects in 40 CFR Part 52
Environmental protection, Air
pollution control, Carbon monoxide,
Incorporation by reference,
Intergovernmental relations, Nitrogen
dioxide, Ozone, Particulate matter,
Reporting and recordkeeping
requirements, Sulfur oxides, Volatile
organic compounds.
Adam Ortiz,
Regional Administrator, Region III.
For the reasons stated in the
preamble, the EPA amends 40 CFR part
52 as follows:
PART 52—APPROVAL AND
PROMULGATION OF
IMPLEMENTATION PLANS
1. The authority citation for part 52
continues to read as follows:
■
Authority: 42 U.S.C. 7401 et seq.
Subpart XX—West Virginia
2. In § 52.2520, the table in paragraph
(c) entitled ‘‘EPA-Approved Regulations
in the West Virginia SIP’’ is amended by
revising the entries for ‘‘Section 45–8–
1’’, ‘‘Section 45–8–2’’, ‘‘Section 45–8–
3’’, and ‘‘Section 45–8–4’’ under the
heading ‘‘[45 CSR] Series 8 Ambient Air
Quality Standards’’ to read as follows:
■
§ 52.2520
*
Identification of plan.
*
*
(c) * * *
*
*
EPA-APPROVED REGULATIONS IN THE WEST VIRGINIA SIP
State citation
[chapter 16–20 or 45
CSR]
State
effective
date
Title/subject
*
*
Additional
explanation/citation at 40
CFR 52.2565
EPA approval
date
*
*
*
*
*
[45 CSR] Series 8 Ambient Air Quality Standards
Section
Section
Section
Section
*
45–8–1
45–8–2
45–8–3
45–8–4
*
..........
..........
..........
..........
General ....................................
Definitions ................................
Adoption of Standards .............
Inconsistency Between Rules
*
*
*
*
*
*
This regulation establishes
tolerances for residues of sodium salt of
acifluorfen in or on berry, low growing,
subgroup 13–07G; soybean, vegetable,
edible podded; and soybean, vegetable,
succulent shelled. The Interregional
Project Number 4 (IR–4) requested these
tolerances under the Federal Food,
Drug, and Cosmetic Act (FFDCA).
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
ddrumheller on DSK120RN23PROD with RULES1
*
SUMMARY:
BILLING CODE 6560–50–P
[EPA–HQ–OPP–2022–0361; FRL–11130–01–
OCSPP]
Sodium Salt of Acifluorfen; Pesticide
Tolerances
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
16:11 Jul 26, 2023
7/27/23 [INSERT FEDERAL REGISTER CITATION]
7/27/23 [INSERT FEDERAL REGISTER CITATION]
7/27/23, [INSERT FEDERAL REGISTER CITATION]
7/27/23, [INSERT FEDERAL REGISTER CITATION]
*
[FR Doc. 2023–15810 Filed 7–26–23; 8:45 am]
VerDate Sep<11>2014
4/1/22
4/1/22
4/1/22
4/1/22
Jkt 259001
This regulation is effective July
27, 2023. Objections and requests for
hearings must be received on or before
September 25, 2023, and must be filed
in accordance with the instructions
provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
INFORMATION).
DATES:
PO 00000
Frm 00033
Fmt 4700
Sfmt 4700
*
..............
..............
.............
.............
Docket
Docket
Docket
Docket
#2022–0656.
#2022–0656.
#2022–0656.
#2022–0656.
*
The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPP–2022–0361, is
available online at https://
www.regulations.gov or in-person at the
Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the
Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room and the OPP
Docket is (202) 566–1744. For the latest
status information on EPA/DC services,
ADDRESSES:
E:\FR\FM\27JYR1.SGM
27JYR1
48384
Federal Register / Vol. 88, No. 143 / Thursday, July 27, 2023 / Rules and Regulations
docket access, visit https://
www.epa.gov/.
FOR FURTHER INFORMATION CONTACT:
Charles Smith, Director, Registration
Division (7505T), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001; main
telephone number: (202) 566–1030;
email address: RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
B. How can I get electronic access to
other related information?
You may access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Office of the Federal Register’s eCFR site at https://www.ecfr.gov/
current/title-40.
ddrumheller on DSK120RN23PROD with RULES1
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2022–0361 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing and must be received
by the Hearing Clerk on or before
September 25, 2023. Addresses for mail
and hand delivery of objections and
hearing requests are provided in 40 CFR
178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
VerDate Sep<11>2014
16:11 Jul 26, 2023
Jkt 259001
(CBI)) for inclusion in the public docket.
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
2022–0361, by one of the following
methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
online instructions for submitting
comments. Do not submit electronically
any information you consider to be CBI
or other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW, Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/. Additional instructions
on commenting or visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/.
II. Summary of Petitioned-For
Tolerance
In the Federal Register of May 20,
2022 (87 FR 30855) (FRL–9410–13–
OCSPP), EPA issued a document
pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing
of pesticide petition (2E8987) by the
Interregional Research Project No. 4 (IR–
4), Project Headquarters, North Carolina
State University, 1730 Varsity Drive,
Venture IV, Suite 210, Raleigh, NC
27606. The petition requested that 40
CFR 180.383 be amended to establish
tolerances for residues of the herbicide
sodium salt of acifluorfen, sodium 5-[2chloro-4-(trifluoromethyl)phenoxy]-2nitrobenzoate, and its metabolites (the
corresponding acid, methyl ester, and
amino analogues) in or on the following
raw agricultural commodities: berry,
low growing, subgroup 13–07G at 0.1
ppm; soybean, vegetable, edible podded
at 0.09 ppm; and soybean, vegetable,
succulent shelled at 0.09 ppm. The
petition also requested that EPA remove
the established tolerance for residues of
sodium salt of acifluorfen in or on
strawberry at 0.05 ppm. That document
referenced a summary of the petition
prepared by IR–4, the petitioner, which
is available in the docket, https://
www.regulations.gov. There were no
comments received on the notice of
filing.
PO 00000
Frm 00034
Fmt 4700
Sfmt 4700
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue. . . .’’
Consistent with FFDCA section
408(b)(2)(D), and the factors specified
therein, EPA has reviewed the available
scientific data and other relevant
information in support of this action.
EPA has sufficient data to assess the
hazards of and to make a determination
on aggregate exposure for sodium salt of
acifluorfen including exposure resulting
from the tolerances established by this
action. EPA’s assessment of exposures
and risks associated with sodium salt of
acifluorfen follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children.
The toxicology database for sodium
salt of acifluorfen is complete and
considered adequate for risk assessment.
EPA has waived the subchronic
inhalation study, subchronic
neurotoxicity studies, and the
developmental neurotoxicity study.
Hematological effects (such as decreases
in erythrocyte count, hematocrit, and/or
mean cell volume) were noted in dog,
rat, and mice. The liver (dog, rat, and
mouse) and kidney (rat and mouse) are
also target organs of oral exposure, and
effects in these organs were noted
following both subchronic and chronic
exposures. Indications of liver toxicity
E:\FR\FM\27JYR1.SGM
27JYR1
Federal Register / Vol. 88, No. 143 / Thursday, July 27, 2023 / Rules and Regulations
ddrumheller on DSK120RN23PROD with RULES1
included findings such as increased
liver weight, hypertrophy, clinical
chemistry findings, urinary
urobilinogen, focal necrosis;
proliferation of oval or bile duct cells,
and fatty infiltration. Indications of
kidney toxicity include increases in the
following parameters: kidney weight;
serum electrolytes, blood urea nitrogen
(BUN), and creatinine; and urinary
nitrate. There was quantitative fetal
susceptibility demonstrated in the
Sprague-Dawley rat developmental
study, but no susceptibility in the
Wistar rat or rabbit developmental
studies, nor in the reproduction study.
There are no genotoxicity, neurotoxicity
or immunotoxicity concerns observed in
the available toxicity studies. In the
dermal toxicity test, skin irritation was
observed at all doses, and systemic
toxicity was noted at the limit dose.
EPA has classified sodium salt of
acifluorfen as ‘‘likely to be carcinogenic
to humans at high enough doses to
cause the biochemical and
histopathological changes in livers of
rodents, but unlikely to be carcinogenic
at doses below those causing these
changes’’. EPA determined that nonlinear extrapolation is appropriate for
risk assessment purposes. The nonlinear reference dose (RfD) approach
will be protective for chronic effects,
including carcinogenicity.
Sodium salt of acifluorfen has low
acute toxicity by the oral and dermal
exposure routes (Toxicity Category III).
However, it is a severe eye irritant
(Toxicity Category I) and moderate
dermal irritant (Toxicity Category II). It
is not considered a skin sensitizer.
Specific information on the studies
received and the nature of the adverse
effects caused by sodium salt of
acifluorfen as well as the no-observedadverse-effect-level (NOAEL) and the
lowest-observed-adverse-effect-level
(LOAEL) from the toxicity studies can
be found at https://www.regulations.gov
in document titled ‘‘Sodium
Acifluorfen. Human Health Risk
Assessment of Proposed Tolerances and
Uses on Edamame (Vegetable Soybean)
and Crop Group Expansion and Use on
Low-growing Berry Subgroup 13–07G’’
(hereinafter ‘‘Sodium Acifluorfen
Human Health Risk Assessment’’) on
pages 24–32 in docket ID number EPA–
HQ–OPP–2022–0361.
B. Toxicological Points of Departure/
Levels of Concern
Once a pesticide’s toxicological
profile is determined, EPA identifies
toxicological points of departure (POD)
and levels of concern to use in
evaluating the risk posed by human
exposure to the pesticide. For hazards
VerDate Sep<11>2014
16:11 Jul 26, 2023
Jkt 259001
that have a threshold below which there
is no appreciable risk, the toxicological
POD is used as the basis for derivation
of reference values for risk assessment.
PODs are developed based on a careful
analysis of the doses in each
toxicological study to determine the
dose at which no adverse effects are
observed (the NOAEL) and the lowest
dose at which adverse effects of concern
are identified (the LOAEL). Uncertainty/
safety factors are used in conjunction
with the POD to calculate a safe
exposure level—generally referred to as
a population-adjusted dose (PAD) or a
reference dose (RfD)—and a safe margin
of exposure (MOE). For non-threshold
risks, the Agency assumes that any
amount of exposure will lead to some
degree of risk. Thus, the Agency
estimates risk in terms of the probability
of an occurrence of the adverse effect
expected in a lifetime. For more
information on the general principles
EPA uses in risk characterization and a
complete description of the risk
assessment process, see https://
www.epa.gov/pesticide-science-andassessing-pesticide-risks/cumulativeassessment-risk-pesticides.
A summary of the toxicological
endpoints for sodium salt of acifluorfen
used for human risk assessment can be
found in the Sodium Acifluorfen
Human Health Risk Assessment on
pages 12–15.
C. Exposure Assessment
1. Dietary exposure from food and
feed uses. In evaluating dietary
exposure to sodium salt of acifluorfen,
EPA considered exposure under the
petitioned-for tolerances as well as all
existing sodium salt of acifluorfen
tolerances in 40 CFR 180.383. EPA
assessed dietary exposures from sodium
salt of acifluorfen in food as follows:
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide,
if a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1-day or single
exposure. Such effects were identified
for sodium salt of acifluorfen.
In estimating the acute dietary
exposure, EPA used the Dietary
Exposure Evaluation Model software
using the Food Commodity Intake
Database (DEEM–FCID) Version 4.02,
which uses the 2005–2010 food
consumption data from the United
States Department of Agriculture’s
(USDA’s) National Health and Nutrition
Examination Survey, What We Eat in
America (NHANES/WWEIA). The acute
dietary exposure assessment assumes
tolerance-level residues and 100% crop
PO 00000
Frm 00035
Fmt 4700
Sfmt 4700
48385
treated (PCT) for all commodities and
incorporates default processing factors.
ii. Chronic exposure. In conducting
the chronic dietary exposure
assessment, EPA used the 2005–2010
food consumption data from the USDA’s
NHANES/WWEIA and DEEM–FCID;
version 4.02. The chronic dietary
exposure assessment assumes tolerancelevel residues and 100 PCT for all
commodities and incorporates default
processing factors.
iii. Cancer. EPA determines whether
quantitative cancer exposure and risk
assessments are appropriate for a fooduse pesticide based on the weight of the
evidence from cancer studies and other
relevant data. If quantitative cancer risk
assessment is appropriate, cancer risk
may be quantified using a linear or
nonlinear approach. If sufficient
information on the carcinogenic mode
of action is available, a threshold or
nonlinear approach is used and a cancer
RfD is calculated based on an earlier
noncancer key event. If carcinogenic
mode of action data are not available, or
if the mode of action data determines a
mutagenic mode of action, a default
linear cancer slope factor approach is
utilized. Based on the data summarized
in Unit III.A., EPA has concluded that
sodium salt of acifluorfen should be
classified as ‘‘Likely to be Carcinogenic
to Humans at high enough doses to
cause the biochemical and
histopathological changes in livers of
rodents, but unlikely to be carcinogenic
at doses below those causing these
changes.’’ The non-linear RfD approach
will be protective for chronic effects,
including carcinogenicity. Cancer risk
was quantified using the same estimates
as discussed in Unit III.C.1.ii., chronic
exposure.
iv. Anticipated residue and PCT
information. EPA did not use
anticipated residue and/or PCT
information in the dietary assessment
for sodium salt of acifluorfen. Tolerance
level residues and/or 100 PCT were
assumed for all food commodities.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
exposure analysis and risk assessment
for sodium salt of acifluorfen in
drinking water. These simulation
models take into account data on the
physical, chemical, and fate/transport
characteristics of sodium salt of
acifluorfen. Further information
regarding EPA drinking water models
used in pesticide exposure assessment
can be found at https://www.epa.gov/
science-and-assessing-pesticide-risks/
pesticide-risk-assessment.
Based on the groundwater modeling
results from Pesticide Root Zone Model
E:\FR\FM\27JYR1.SGM
27JYR1
ddrumheller on DSK120RN23PROD with RULES1
48386
Federal Register / Vol. 88, No. 143 / Thursday, July 27, 2023 / Rules and Regulations
for Ground Water (PRZM–GW), the
estimated drinking water concentrations
(EDWCs) of sodium salt of acifluorfen
for acute and chronic exposures are
estimated to be 146 parts per billion
(ppb) for ground water. These modeled
estimates of drinking water
concentrations were directly entered
into the dietary exposure model.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., for lawn and garden pest control,
indoor pest control, termiticides, and
flea and tick control on pets). Sodium
salt of acifluorfen is not registered for
any specific use patterns that would
result in residential exposure, and the
new uses would not result in residential
exposures; therefore, direct exposures in
residential settings are not expected for
adults and children.
Further information regarding EPA
standard assumptions and generic
inputs for residential exposures may be
found at https://www.epa.gov/pesticidescience-and-assessing-pesticide-risks/
operating-procedures-residentialpesticide.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
Unlike other pesticides for which EPA
has followed a cumulative risk approach
based on a common mechanism of
toxicity, EPA has not made a common
mechanism of toxicity finding as to
sodium salt of acifluorfen and any other
substances, and sodium salt of
acifluorfen does not appear to produce
a toxic metabolite produced by other
substances. For the purposes of this
action, therefore, EPA has not assumed
that sodium salt of acifluorfen has a
common mechanism of toxicity with
other substances.
For information regarding EPA’s
efforts to determine which chemicals
have a common mechanism of toxicity
and to evaluate the cumulative effects of
such chemicals, see EPA’s website at
https://www.epa.gov/pesticide-scienceand-assessing-pesticide-risks/
cumulative-assessment-risk-pesticides.
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(C) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
VerDate Sep<11>2014
16:11 Jul 26, 2023
Jkt 259001
safety for infants and children in the
case of threshold effects to account for
prenatal and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines,
based on reliable data, that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
Food Quality Protection Act (FQPA)
Safety Factor (SF). In applying this
provision, EPA either retains the default
value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
2. Prenatal and postnatal sensitivity.
There is evidence of increased
susceptibility following in utero
exposure to sodium salt of acifluorfen in
the Sprague Dawley rat developmental
toxicity study. However, there is low
concern for developmental toxicity
because the effects are well
characterized with clear NOAEL/LOAEL
values and the chosen points of
departure for risk assessment for each
scenario are protective of these effects.
3. Conclusion. EPA has determined
that reliable data show that the safety of
infants and children would be
adequately protected if the FQPA SF
were reduced from 10X to 1X. That
decision is based on the following
findings:
i. The toxicity database for sodium
salt of acifluorfen is complete.
ii. The weight of evidence (WOE)
suggests that sodium salt of acifluorfen
is not neurotoxic. This conclusion is
based on the following: (1) indications
of treatment-related toxicity in the acute
neurotoxicity study (ACN) are wellcharacterized, and the decreased motor
activity observed could be an indication
of systemic toxicity from the bolus dose;
(2) the slight effect observed in fetuses
in a developmental toxicity study with
Sprague-Dawley rats (dilated brain
ventricles) were not reproduced in
another developmental toxicity study
with Wistar rats nor in developmental
toxicity studies with rabbits; and (3)
there was no indication of treatmentrelated neurotoxicity observed in any
studies for structurally-related
chemicals (fomesafen, lactofen, and
oxyfluorfen), except for decreased motor
activity in an acute neurotoxicity study
with fomesafen at the same dose where
general systemic toxicity (body weight
loss) was observed. No immunotoxicity
was observed. In the dermal toxicity
test, skin irritation was observed at all
doses, and systemic toxicity was noted
at the limit dose.
iii. There is evidence that sodium salt
of acifluorfen results in increased
susceptibility following exposure in
PO 00000
Frm 00036
Fmt 4700
Sfmt 4700
utero rats in the Sprague Dawley rat
prenatal developmental study. However,
there is low concern because effects are
well characterized with clear NOAEL/
LOAEL values and the chosen points of
departure for risk assessment for each
scenario are protective of these effects.
iv. There are no residual uncertainties
identified in the exposure database. The
dietary food exposure assessments were
performed based on 100 PCT and
tolerance-level residues. EPA made
conservative (protective) assumptions in
the ground and surface water modeling
used to assess exposure to sodium salt
of acifluorfen in drinking water. These
assessments will not underestimate the
exposure and risks posed by sodium salt
of acifluorfen.
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic dietary pesticide exposures are
safe by comparing dietary exposure
estimates to the acute population
adjusted dose (aPAD) and the chronic
population adjusted dose (cPAD).
Short-, intermediate-, and chronic term
aggregate risks are evaluated by
comparing the estimated total food,
water, and residential exposure to the
appropriate PODs to ensure that an
adequate MOE exists.
1. Acute risk. An acute aggregate risk
takes into account exposure estimated
from dietary consumption of food and
drinking water. Using the exposure
assumptions described in this unit for
acute exposure, EPA has concluded that
acute exposure to sodium salt of
acifluorfen will occupy less than 1% of
the aPAD for all infants less than 1 year
old, the population group receiving the
greatest exposure. There are no
registered residential uses of sodium
salt of acifluorfen so acute aggregate risk
is equivalent to acute dietary risk,
which is not of concern. A separate,
lower POD was selected for females 13
to 49 years old for which the estimated
risk was 3.9% of the aPAD.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to sodium salt of
acifluorfen from food and water will
utilize 87% of the cPAD for all infants
less than 1 year old, the population
group receiving the greatest exposure.
There are no registered residential uses
of sodium salt of acifluorfen, so chronic
aggregate risk is equivalent to chronic
dietary risk, which is not of concern.
3. Short-term/Intermediate-term risk.
Short- and intermediate-term aggregate
exposure take into account short- and
intermediate-term residential exposure
plus chronic exposure to food and water
E:\FR\FM\27JYR1.SGM
27JYR1
Federal Register / Vol. 88, No. 143 / Thursday, July 27, 2023 / Rules and Regulations
(considered to be a background
exposure level). A short-term and an
intermediate-term adverse effect were
identified; however, sodium salt of
acifluorfen is not registered for any use
patterns that would result in short- or
intermediate-term residential exposure.
Short- and intermediate-term risk is
assessed based on short- and
intermediate-term residential exposure
plus chronic dietary exposure. Because
there is no short- or intermediate-term
residential exposure and chronic dietary
exposure has already been assessed
under the appropriately protective
cPAD (which is at least as protective as
the POD used to assess short- or
intermediate-term risk), no further
assessment of short- or intermediateterm risk is necessary, and EPA relies on
the chronic dietary risk assessment for
evaluating short- and intermediate-term
risk for sodium salt of acifluorfen
4. Aggregate cancer risk for U.S.
population. As explained in Unit III.A.,
sodium salt of acifluorfen is classified as
‘‘likely to be carcinogenic to humans at
doses high enough to cause the
biochemical and histopathological
changes in livers of rodents, but
unlikely to be carcinogenic at doses
below those causing these changes.’’
EPA determined that the non-linear RfD
approach will be protective for chronic
effects, including carcinogenicity.
Because the chronic risks are below
EPA’s level of concern, sodium salt of
acifluorfen is not expected to pose a
cancer risk to humans.
5. Determination of safety. Based on
these risk assessments, EPA concludes
that there is a reasonable certainty that
no harm will result to the general
population, or to infants and children,
from aggregate exposure to sodium salt
of acifluorfen residues.
IV. Other Considerations
ddrumheller on DSK120RN23PROD with RULES1
A. Analytical Enforcement Methodology
Adequate methods are available for
enforcement of tolerances of sodium salt
of acifluorfen in the Pesticide Analytical
Manual (PAM) Volume II. PAM Volume
II lists a gas chromatography/electron
capture detector (GC/ECD) method,
(Method I), for the determination of
sodium salt of acifluorfen in/on plant
commodities. Identifications are
confirmed by gas chromatograph
equipped with a mass spectroscopy
(GC/MS), Method A in PAM II.
B. International Residue Limits
In making its tolerance decisions, EPA
seeks to harmonize U.S. tolerances with
international standards whenever
possible, consistent with U.S. food
safety standards and agricultural
VerDate Sep<11>2014
16:11 Jul 26, 2023
Jkt 259001
practices. EPA considers the
international maximum residue limits
(MRLs) established by the Codex
Alimentarius Commission (Codex), as
required by FFDCA section 408(b)(4).
Codex has not established any MRLs
for sodium salt of acifluorfen; thus,
harmonization is not an issue.
V. Conclusion
Therefore, tolerances are established
for residues of sodium salt of
acifluorfen, including its metabolites
and degradates, in or on the following
commodities: berry, low growing,
subgroup 13–07G at 0.1 ppm; soybean,
vegetable, edible podded at 0.09 ppm
and soybean, vegetable, succulent
shelled at 0.09 ppm. Additionally, EPA
is removing the established tolerance for
residues of sodium salt of acifluorfen in
or on strawberry at 0.05 ppm.
VI. Statutory and Executive Order
Reviews
This action establishes tolerances
under FFDCA section 408(d) in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled ‘‘Regulatory
Planning and Review’’ (58 FR 51735,
October 4, 1993). Because this action
has been exempted from review under
Executive Order 12866, this action is
not subject to Executive Order 13211,
entitled ‘‘Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use’’ (66
FR 28355, May 22, 2001), or Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997). This action does not
contain any information collections
subject to OMB approval under the
Paperwork Reduction Act (PRA) (44
U.S.C. 3501 et seq.), nor does it require
any special considerations under
Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerances in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers,
food processors, food handlers, and food
retailers, not States or Tribes, nor does
this action alter the relationships or
distribution of power and
PO 00000
Frm 00037
Fmt 4700
Sfmt 4700
48387
responsibilities established by Congress
in the preemption provisions of FFDCA
section 408(n)(4). As such, the Agency
has determined that this action will not
have a substantial direct effect on States
or Tribal Governments, on the
relationship between the National
Government and the States or Tribal
Governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
Tribes. Thus, the Agency has
determined that Executive Order 13132,
entitled ‘‘Federalism’’ (64 FR 43255,
August 10, 1999), and Executive Order
13175, entitled ‘‘Consultation and
Coordination with Indian Tribal
Governments’’ (65 FR 67249, November
9, 2000), do not apply to this action. In
addition, this action does not impose
any enforceable duty or contain any
unfunded mandate as described under
Title II of the Unfunded Mandates
Reform Act (UMRA) (2 U.S.C. 1501 et
seq.).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act
(NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: July 19, 2023.
Charles Smith,
Director, Registration Division, Office of
Pesticide Programs.
Therefore, for the reasons stated in the
preamble, EPA is amending 40 CFR
chapter I as follows:
PART 180—TOLERANCES AND
EXEMPTIONS FOR PESTICIDE
CHEMICAL RESIDUES IN FOOD
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
E:\FR\FM\27JYR1.SGM
27JYR1
48388
Federal Register / Vol. 88, No. 143 / Thursday, July 27, 2023 / Rules and Regulations
August 3, 2023 at 6 p.m. and
implements a fishing period catch limit
of 1,000 pounds (lb) (0.45 mt) dressed
weight for all vessel size classes. This
action is intended to conserve Pacific
halibut and provide commercial fishing
opportunity where available.
DATES: Effective date: July 24, 2023,
through December 31, 2023.
FOR FURTHER INFORMATION CONTACT:
Melissa Mandrup, 562–980–3231,
Melissa.Mandrup@noaa.gov.
SUPPLEMENTARY INFORMATION: On June
26, 2023, NMFS published a final rule
implementing harvest specifications,
§ 180.383 Sodium salt of acifluorfen;
fishing periods, and fishing period
tolerances for residues.
limits by vessel size class for the Area
(a) * * *
2A non-tribal directed commercial
Pacific halibut fishery (88 FR 41334), as
TABLE 1 TO PARAGRAPH (a)
authorized by the Northern Pacific
Halibut Act of 1982 (16 U.S.C. 773–
Parts
per
Commodity
773(k)). The Pacific Fishery
million
Management Council 2023 Catch
Berry, low growing, subgroup
Sharing Plan provides a recommended
13–07G ...................................
0.1 framework for NMFS’ management
considerations and allocations based on
*
*
*
*
*
the 2023 Area 2A Pacific halibut catch
Soybean, vegetable, edible podded ..........................................
0.09 limit of 1,520,000 pounds (lb) (689
metric tons (mt)) set by the International
Soybean, vegetable, succulent
shelled .....................................
0.09 Pacific Halibut Commission (IPHC). The
Area 2A catch limit and commercial
fishery allocations were adopted by the
*
*
*
*
*
[FR Doc. 2023–15900 Filed 7–26–23; 8:45 am]
IPHC and were published in the Federal
Register on March 7, 2023 (88 FR
BILLING CODE 6560–50–P
14066) after acceptance by the Secretary
of State, with concurrence from the
Secretary of Commerce, in accordance
DEPARTMENT OF COMMERCE
with 50 CFR 300.62.
Per a final rule published on June 26,
National Oceanic and Atmospheric
2023 (88 FR 41334), two fishing periods
Administration
were set for the 2023 directed
commercial Pacific halibut fishery; the
50 CFR Part 300
first fishing period began on June 27,
[Docket No. 230615–0151; RTID 0648–
2023 at 8 a.m. and closed on June 29 at
XD142]
6 p.m. and the second fishing period
opened on July 11, 2023 at 8 a.m. and
Pacific Halibut Fisheries of the West
closed on July 13 at 6 p.m. Fishing
Coast; Inseason Action for the 2023
period limits for the fishing periods
Area 2A Pacific Halibut Directed
announced in the final rule varied by
Commercial Fishery
vessel size class, ranging from 2,716 lb
AGENCY: National Marine Fisheries
(1.23 mt) to 6,136 lb (2.78 mt). Federal
Service (NMFS), National Oceanic and
regulations at 50 CFR 300.63(e)(1)(iii),
Atmospheric Administration (NOAA),
‘‘Inseason action to add fishing periods
Commerce.
and associated fishing period limits,’’
allow the NMFS Regional Administrator
ACTION: Temporary rule; inseason
to add fishing periods as needed to
adjustment.
attain the directed commercial fishery
SUMMARY: NMFS announces an inseason allocation. Fishing period limits, for
action for the 2023 non-tribal directed
those fishing periods added inseason,
commercial Pacific halibut fishery that
are equal across all vessel size classes.
operates south of Point Chehalis,
Landings information at the
Washington (lat. 46°53.30′ N) in the
conclusion of the second fishing period
International Pacific Halibut
indicate that sufficient allocation
Commission’s regulatory Area 2A off
remains to warrant an additional fishing
Washington, Oregon, and California.
period without exceeding the allocation
Specifically, this action adds an
for the Area 2A directed commercial
additional fishing period beginning on
fishery. As stated above, inseason
August 1, 2023 at 8 a.m. and closing on
addition of fishing periods with fishing
2. In § 180.383, amend paragraph (a)
by:
■ a. Designating the table to paragraph
(a); and
■ b. In newly designated table 1 to
paragraph (a):
■ i. Adding in alphabetical order the
entries ‘‘Berry, low growing, subgroup
13–07G’’; ‘‘Soybean, vegetable, edible
podded’’; and ‘‘Soybean, vegetable,
succulent shelled’’; and
■ ii. Removing the entry for
‘‘Strawberry’’.
The additions read as follows:
ddrumheller on DSK120RN23PROD with RULES1
■
VerDate Sep<11>2014
16:11 Jul 26, 2023
Jkt 259001
PO 00000
Frm 00038
Fmt 4700
Sfmt 4700
period limits equal across all vessel size
classes is authorized by Federal
regulations at 50 CFR 300.63(e)(1)(iii)
and was announced in the final rule (88
FR 41334, June 26, 2023). NMFS
determined the following inseason
action is necessary to meet the
management objective of attaining the
directed commercial fishery allocation,
will not result in exceeding the
allocation, and is consistent with the
inseason management provisions
allowing for additional fishing periods.
Notice of this additional fishing period
and fishing period limits will also be
announced on the NMFS hotline at 206–
526–6667 or 800–662–9825.
Inseason Action
Description of the action: This
inseason action implements an
additional fishing period, beginning
August 1, 2023 at 8 a.m. and ending on
August 3, 2023 at 6 p.m. This inseason
action also implements a fishing period
catch limit of 1,000 lb (0.45 mt) dressed
weight (880 lb (0.40 mt) net weight) for
all vessel size classes.
Reason for the action: The purpose of
this inseason action is to provide
additional opportunity for commercial
halibut fishery participants in Area 2A.
The first fishing period opened on June
27, 2023 at 8 a.m. and closed on June
29, 2023 at 6 p.m. The second fishing
period opened on July 11, 2023 at 8 a.m.
and closed on July 13, 2023 at 6 p.m.
NMFS has determined that an
additional fishing period is warranted
because sufficient allocation remains
and that a substantial amount of the
allocation will go unharvested without
an additional fishing period.
As of July 19, approximately 223,261
lb (101.27 mt), net weight, have been
harvested of the 257,819 lb (116.95 mt)
allocation (87 percent), leaving 34,558
lb (15.68 mt) remaining (13 percent).
With little risk of the directed
commercial fishery allocation being
exceeded, an additional fishing period
is warranted for participants in the
directed commercial fishery. Therefore,
through this action, NMFS is adding one
fishing period not previously
implemented in the final rule on June
26, 2023 (88 FR 41334). Specifically, an
additional fishing period is announced
for August 1, 2023 at 8 a.m. until August
3, 2023 at 6 p.m.
Fishing period limits for the two
fishing periods, implemented in the
final rule (88 FR 41334, June 26, 2023),
varied across vessel size classes, ranging
from 2,715 lbs. (1.23 mt) to 6,135 lbs.
(2.78 mt), and were based on the
number of permits issued and the
allocation. Fishing period limits
implemented through inseason action
E:\FR\FM\27JYR1.SGM
27JYR1
Agencies
[Federal Register Volume 88, Number 143 (Thursday, July 27, 2023)]
[Rules and Regulations]
[Pages 48383-48388]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15900]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2022-0361; FRL-11130-01-OCSPP]
Sodium Salt of Acifluorfen; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of sodium
salt of acifluorfen in or on berry, low growing, subgroup 13-07G;
soybean, vegetable, edible podded; and soybean, vegetable, succulent
shelled. The Interregional Project Number 4 (IR-4) requested these
tolerances under the Federal Food, Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective July 27, 2023. Objections and
requests for hearings must be received on or before September 25, 2023,
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2022-0361, is available online at
https://www.regulations.gov or in-person at the Office of Pesticide
Programs Regulatory Public Docket (OPP Docket) in the Environmental
Protection Agency Docket Center (EPA/DC), West William Jefferson
Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW, Washington, DC
20460-0001. The Public Reading Room is open from 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding legal holidays. The telephone
number for the Public Reading Room and the OPP Docket is (202) 566-
1744. For the latest status information on EPA/DC services,
[[Page 48384]]
docket access, visit https://www.epa.gov/.
FOR FURTHER INFORMATION CONTACT: Charles Smith, Director, Registration
Division (7505T), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; main telephone number: (202) 566-1030; email address:
[email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of EPA's
tolerance regulations at 40 CFR part 180 through the Office of the
Federal Register's e-CFR site at https://www.ecfr.gov/current/title-40.
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2022-0361 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing and must be received by the Hearing Clerk on or before
September 25, 2023. Addresses for mail and hand delivery of objections
and hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2022-0361, by one of
the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/. Additional instructions on
commenting or visiting the docket, along with more information about
dockets generally, is available at https://www.epa.gov/.
II. Summary of Petitioned-For Tolerance
In the Federal Register of May 20, 2022 (87 FR 30855) (FRL-9410-13-
OCSPP), EPA issued a document pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing of pesticide petition (2E8987)
by the Interregional Research Project No. 4 (IR-4), Project
Headquarters, North Carolina State University, 1730 Varsity Drive,
Venture IV, Suite 210, Raleigh, NC 27606. The petition requested that
40 CFR 180.383 be amended to establish tolerances for residues of the
herbicide sodium salt of acifluorfen, sodium 5-[2-chloro-4-
(trifluoromethyl)phenoxy]-2-nitrobenzoate, and its metabolites (the
corresponding acid, methyl ester, and amino analogues) in or on the
following raw agricultural commodities: berry, low growing, subgroup
13-07G at 0.1 ppm; soybean, vegetable, edible podded at 0.09 ppm; and
soybean, vegetable, succulent shelled at 0.09 ppm. The petition also
requested that EPA remove the established tolerance for residues of
sodium salt of acifluorfen in or on strawberry at 0.05 ppm. That
document referenced a summary of the petition prepared by IR-4, the
petitioner, which is available in the docket, https://www.regulations.gov. There were no comments received on the notice of
filing.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue. . .
.''
Consistent with FFDCA section 408(b)(2)(D), and the factors
specified therein, EPA has reviewed the available scientific data and
other relevant information in support of this action. EPA has
sufficient data to assess the hazards of and to make a determination on
aggregate exposure for sodium salt of acifluorfen including exposure
resulting from the tolerances established by this action. EPA's
assessment of exposures and risks associated with sodium salt of
acifluorfen follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
The toxicology database for sodium salt of acifluorfen is complete
and considered adequate for risk assessment. EPA has waived the
subchronic inhalation study, subchronic neurotoxicity studies, and the
developmental neurotoxicity study. Hematological effects (such as
decreases in erythrocyte count, hematocrit, and/or mean cell volume)
were noted in dog, rat, and mice. The liver (dog, rat, and mouse) and
kidney (rat and mouse) are also target organs of oral exposure, and
effects in these organs were noted following both subchronic and
chronic exposures. Indications of liver toxicity
[[Page 48385]]
included findings such as increased liver weight, hypertrophy, clinical
chemistry findings, urinary urobilinogen, focal necrosis; proliferation
of oval or bile duct cells, and fatty infiltration. Indications of
kidney toxicity include increases in the following parameters: kidney
weight; serum electrolytes, blood urea nitrogen (BUN), and creatinine;
and urinary nitrate. There was quantitative fetal susceptibility
demonstrated in the Sprague-Dawley rat developmental study, but no
susceptibility in the Wistar rat or rabbit developmental studies, nor
in the reproduction study. There are no genotoxicity, neurotoxicity or
immunotoxicity concerns observed in the available toxicity studies. In
the dermal toxicity test, skin irritation was observed at all doses,
and systemic toxicity was noted at the limit dose.
EPA has classified sodium salt of acifluorfen as ``likely to be
carcinogenic to humans at high enough doses to cause the biochemical
and histopathological changes in livers of rodents, but unlikely to be
carcinogenic at doses below those causing these changes''. EPA
determined that non-linear extrapolation is appropriate for risk
assessment purposes. The non-linear reference dose (RfD) approach will
be protective for chronic effects, including carcinogenicity.
Sodium salt of acifluorfen has low acute toxicity by the oral and
dermal exposure routes (Toxicity Category III). However, it is a severe
eye irritant (Toxicity Category I) and moderate dermal irritant
(Toxicity Category II). It is not considered a skin sensitizer.
Specific information on the studies received and the nature of the
adverse effects caused by sodium salt of acifluorfen as well as the no-
observed-adverse-effect-level (NOAEL) and the lowest-observed-adverse-
effect-level (LOAEL) from the toxicity studies can be found at https://www.regulations.gov in document titled ``Sodium Acifluorfen. Human
Health Risk Assessment of Proposed Tolerances and Uses on Edamame
(Vegetable Soybean) and Crop Group Expansion and Use on Low-growing
Berry Subgroup 13-07G'' (hereinafter ``Sodium Acifluorfen Human Health
Risk Assessment'') on pages 24-32 in docket ID number EPA-HQ-OPP-2022-
0361.
B. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which no adverse effects are observed (the NOAEL)
and the lowest dose at which adverse effects of concern are identified
(the LOAEL). Uncertainty/safety factors are used in conjunction with
the POD to calculate a safe exposure level--generally referred to as a
population-adjusted dose (PAD) or a reference dose (RfD)--and a safe
margin of exposure (MOE). For non-threshold risks, the Agency assumes
that any amount of exposure will lead to some degree of risk. Thus, the
Agency estimates risk in terms of the probability of an occurrence of
the adverse effect expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides.
A summary of the toxicological endpoints for sodium salt of
acifluorfen used for human risk assessment can be found in the Sodium
Acifluorfen Human Health Risk Assessment on pages 12-15.
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to sodium salt of acifluorfen, EPA considered exposure under
the petitioned-for tolerances as well as all existing sodium salt of
acifluorfen tolerances in 40 CFR 180.383. EPA assessed dietary
exposures from sodium salt of acifluorfen in food as follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure. Such effects were identified
for sodium salt of acifluorfen.
In estimating the acute dietary exposure, EPA used the Dietary
Exposure Evaluation Model software using the Food Commodity Intake
Database (DEEM-FCID) Version 4.02, which uses the 2005-2010 food
consumption data from the United States Department of Agriculture's
(USDA's) National Health and Nutrition Examination Survey, What We Eat
in America (NHANES/WWEIA). The acute dietary exposure assessment
assumes tolerance-level residues and 100% crop treated (PCT) for all
commodities and incorporates default processing factors.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment, EPA used the 2005-2010 food consumption data from the
USDA's NHANES/WWEIA and DEEM-FCID; version 4.02. The chronic dietary
exposure assessment assumes tolerance-level residues and 100 PCT for
all commodities and incorporates default processing factors.
iii. Cancer. EPA determines whether quantitative cancer exposure
and risk assessments are appropriate for a food-use pesticide based on
the weight of the evidence from cancer studies and other relevant data.
If quantitative cancer risk assessment is appropriate, cancer risk may
be quantified using a linear or nonlinear approach. If sufficient
information on the carcinogenic mode of action is available, a
threshold or nonlinear approach is used and a cancer RfD is calculated
based on an earlier noncancer key event. If carcinogenic mode of action
data are not available, or if the mode of action data determines a
mutagenic mode of action, a default linear cancer slope factor approach
is utilized. Based on the data summarized in Unit III.A., EPA has
concluded that sodium salt of acifluorfen should be classified as
``Likely to be Carcinogenic to Humans at high enough doses to cause the
biochemical and histopathological changes in livers of rodents, but
unlikely to be carcinogenic at doses below those causing these
changes.'' The non-linear RfD approach will be protective for chronic
effects, including carcinogenicity. Cancer risk was quantified using
the same estimates as discussed in Unit III.C.1.ii., chronic exposure.
iv. Anticipated residue and PCT information. EPA did not use
anticipated residue and/or PCT information in the dietary assessment
for sodium salt of acifluorfen. Tolerance level residues and/or 100 PCT
were assumed for all food commodities.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for sodium salt of acifluorfen in drinking water. These
simulation models take into account data on the physical, chemical, and
fate/transport characteristics of sodium salt of acifluorfen. Further
information regarding EPA drinking water models used in pesticide
exposure assessment can be found at https://www.epa.gov/science-and-assessing-pesticide-risks/pesticide-risk-assessment.
Based on the groundwater modeling results from Pesticide Root Zone
Model
[[Page 48386]]
for Ground Water (PRZM-GW), the estimated drinking water concentrations
(EDWCs) of sodium salt of acifluorfen for acute and chronic exposures
are estimated to be 146 parts per billion (ppb) for ground water. These
modeled estimates of drinking water concentrations were directly
entered into the dietary exposure model.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets). Sodium salt of
acifluorfen is not registered for any specific use patterns that would
result in residential exposure, and the new uses would not result in
residential exposures; therefore, direct exposures in residential
settings are not expected for adults and children.
Further information regarding EPA standard assumptions and generic
inputs for residential exposures may be found at https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/operating-procedures-residential-pesticide.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
Unlike other pesticides for which EPA has followed a cumulative
risk approach based on a common mechanism of toxicity, EPA has not made
a common mechanism of toxicity finding as to sodium salt of acifluorfen
and any other substances, and sodium salt of acifluorfen does not
appear to produce a toxic metabolite produced by other substances. For
the purposes of this action, therefore, EPA has not assumed that sodium
salt of acifluorfen has a common mechanism of toxicity with other
substances.
For information regarding EPA's efforts to determine which
chemicals have a common mechanism of toxicity and to evaluate the
cumulative effects of such chemicals, see EPA's website at https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines, based on reliable data, that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the Food Quality
Protection Act (FQPA) Safety Factor (SF). In applying this provision,
EPA either retains the default value of 10X, or uses a different
additional safety factor when reliable data available to EPA support
the choice of a different factor.
2. Prenatal and postnatal sensitivity. There is evidence of
increased susceptibility following in utero exposure to sodium salt of
acifluorfen in the Sprague Dawley rat developmental toxicity study.
However, there is low concern for developmental toxicity because the
effects are well characterized with clear NOAEL/LOAEL values and the
chosen points of departure for risk assessment for each scenario are
protective of these effects.
3. Conclusion. EPA has determined that reliable data show that the
safety of infants and children would be adequately protected if the
FQPA SF were reduced from 10X to 1X. That decision is based on the
following findings:
i. The toxicity database for sodium salt of acifluorfen is
complete.
ii. The weight of evidence (WOE) suggests that sodium salt of
acifluorfen is not neurotoxic. This conclusion is based on the
following: (1) indications of treatment-related toxicity in the acute
neurotoxicity study (ACN) are well-characterized, and the decreased
motor activity observed could be an indication of systemic toxicity
from the bolus dose; (2) the slight effect observed in fetuses in a
developmental toxicity study with Sprague-Dawley rats (dilated brain
ventricles) were not reproduced in another developmental toxicity study
with Wistar rats nor in developmental toxicity studies with rabbits;
and (3) there was no indication of treatment-related neurotoxicity
observed in any studies for structurally-related chemicals (fomesafen,
lactofen, and oxyfluorfen), except for decreased motor activity in an
acute neurotoxicity study with fomesafen at the same dose where general
systemic toxicity (body weight loss) was observed. No immunotoxicity
was observed. In the dermal toxicity test, skin irritation was observed
at all doses, and systemic toxicity was noted at the limit dose.
iii. There is evidence that sodium salt of acifluorfen results in
increased susceptibility following exposure in utero rats in the
Sprague Dawley rat prenatal developmental study. However, there is low
concern because effects are well characterized with clear NOAEL/LOAEL
values and the chosen points of departure for risk assessment for each
scenario are protective of these effects.
iv. There are no residual uncertainties identified in the exposure
database. The dietary food exposure assessments were performed based on
100 PCT and tolerance-level residues. EPA made conservative
(protective) assumptions in the ground and surface water modeling used
to assess exposure to sodium salt of acifluorfen in drinking water.
These assessments will not underestimate the exposure and risks posed
by sodium salt of acifluorfen.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing dietary exposure estimates to the acute
population adjusted dose (aPAD) and the chronic population adjusted
dose (cPAD). Short-, intermediate-, and chronic term aggregate risks
are evaluated by comparing the estimated total food, water, and
residential exposure to the appropriate PODs to ensure that an adequate
MOE exists.
1. Acute risk. An acute aggregate risk takes into account exposure
estimated from dietary consumption of food and drinking water. Using
the exposure assumptions described in this unit for acute exposure, EPA
has concluded that acute exposure to sodium salt of acifluorfen will
occupy less than 1% of the aPAD for all infants less than 1 year old,
the population group receiving the greatest exposure. There are no
registered residential uses of sodium salt of acifluorfen so acute
aggregate risk is equivalent to acute dietary risk, which is not of
concern. A separate, lower POD was selected for females 13 to 49 years
old for which the estimated risk was 3.9% of the aPAD.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
sodium salt of acifluorfen from food and water will utilize 87% of the
cPAD for all infants less than 1 year old, the population group
receiving the greatest exposure. There are no registered residential
uses of sodium salt of acifluorfen, so chronic aggregate risk is
equivalent to chronic dietary risk, which is not of concern.
3. Short-term/Intermediate-term risk. Short- and intermediate-term
aggregate exposure take into account short- and intermediate-term
residential exposure plus chronic exposure to food and water
[[Page 48387]]
(considered to be a background exposure level). A short-term and an
intermediate-term adverse effect were identified; however, sodium salt
of acifluorfen is not registered for any use patterns that would result
in short- or intermediate-term residential exposure. Short- and
intermediate-term risk is assessed based on short- and intermediate-
term residential exposure plus chronic dietary exposure. Because there
is no short- or intermediate-term residential exposure and chronic
dietary exposure has already been assessed under the appropriately
protective cPAD (which is at least as protective as the POD used to
assess short- or intermediate-term risk), no further assessment of
short- or intermediate-term risk is necessary, and EPA relies on the
chronic dietary risk assessment for evaluating short- and intermediate-
term risk for sodium salt of acifluorfen
4. Aggregate cancer risk for U.S. population. As explained in Unit
III.A., sodium salt of acifluorfen is classified as ``likely to be
carcinogenic to humans at doses high enough to cause the biochemical
and histopathological changes in livers of rodents, but unlikely to be
carcinogenic at doses below those causing these changes.'' EPA
determined that the non-linear RfD approach will be protective for
chronic effects, including carcinogenicity. Because the chronic risks
are below EPA's level of concern, sodium salt of acifluorfen is not
expected to pose a cancer risk to humans.
5. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children, from aggregate
exposure to sodium salt of acifluorfen residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate methods are available for enforcement of tolerances of
sodium salt of acifluorfen in the Pesticide Analytical Manual (PAM)
Volume II. PAM Volume II lists a gas chromatography/electron capture
detector (GC/ECD) method, (Method I), for the determination of sodium
salt of acifluorfen in/on plant commodities. Identifications are
confirmed by gas chromatograph equipped with a mass spectroscopy (GC/
MS), Method A in PAM II.
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4).
Codex has not established any MRLs for sodium salt of acifluorfen;
thus, harmonization is not an issue.
V. Conclusion
Therefore, tolerances are established for residues of sodium salt
of acifluorfen, including its metabolites and degradates, in or on the
following commodities: berry, low growing, subgroup 13-07G at 0.1 ppm;
soybean, vegetable, edible podded at 0.09 ppm and soybean, vegetable,
succulent shelled at 0.09 ppm. Additionally, EPA is removing the
established tolerance for residues of sodium salt of acifluorfen in or
on strawberry at 0.05 ppm.
VI. Statutory and Executive Order Reviews
This action establishes tolerances under FFDCA section 408(d) in
response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993). Because this action has been
exempted from review under Executive Order 12866, this action is not
subject to Executive Order 13211, entitled ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001), or Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997). This action does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA) (44 U.S.C. 3501 et seq.), nor does it require any
special considerations under Executive Order 12898, entitled ``Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerances in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers, food processors, food
handlers, and food retailers, not States or Tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
Tribal Governments, on the relationship between the National Government
and the States or Tribal Governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian Tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999), and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000), do not apply to this action. In addition,
this action does not impose any enforceable duty or contain any
unfunded mandate as described under Title II of the Unfunded Mandates
Reform Act (UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: July 19, 2023.
Charles Smith,
Director, Registration Division, Office of Pesticide Programs.
Therefore, for the reasons stated in the preamble, EPA is amending
40 CFR chapter I as follows:
PART 180--TOLERANCES AND EXEMPTIONS FOR PESTICIDE CHEMICAL RESIDUES
IN FOOD
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
[[Page 48388]]
0
2. In Sec. 180.383, amend paragraph (a) by:
0
a. Designating the table to paragraph (a); and
0
b. In newly designated table 1 to paragraph (a):
0
i. Adding in alphabetical order the entries ``Berry, low growing,
subgroup 13-07G''; ``Soybean, vegetable, edible podded''; and
``Soybean, vegetable, succulent shelled''; and
0
ii. Removing the entry for ``Strawberry''.
The additions read as follows:
Sec. 180.383 Sodium salt of acifluorfen; tolerances for residues.
(a) * * *
Table 1 to Paragraph (a)
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
Berry, low growing, subgroup 13-07G......................... 0.1
* * * * *
Soybean, vegetable, edible podded........................... 0.09
Soybean, vegetable, succulent shelled....................... 0.09
------------------------------------------------------------------------
* * * * *
[FR Doc. 2023-15900 Filed 7-26-23; 8:45 am]
BILLING CODE 6560-50-P